Experimental animal models of drug-induced sensorineural hearing loss: a narrative review

Xuexin Lin1, Jia Luo1, Jingqian Tan2

  • 1Department of Otolaryngology Head and Neck Surgery, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

Abstract

Insights

This review covers animal models of sensorineural hearing loss (SNHL) induced by ototoxic agents, highlighting their use in understanding hearing mechanisms and auditory system function.

Area of Science:

  • Ototoxicology
  • Auditory Neuroscience
  • Experimental Otology

Background:

  • Sensorineural hearing loss (SNHL) stems from damage to the inner ear's sensory organ or the vestibulocochlear nerve (cranial nerve VIII).
  • Key causes of SNHL include genetics, aging (presbycusis), ototoxic agents, infections, and noise exposure.
  • Animal models are crucial for studying SNHL mechanisms and treatments, often utilizing ototoxic agents to induce damage.

Purpose of the Study:

  • To review experimental animal models of sensorineural hearing loss (SNHL) induced by ototoxic agents.
  • To explore the utility of these models in advancing the understanding of hearing mechanisms and auditory system function.

Main Methods:

  • A comprehensive literature search was conducted across PubMed, Embase, and Web of Science.
  • The search focused on research articles detailing hearing loss and ototoxic agents in animal models.

Main Results:

  • Aminoglycoside antibiotics (AABs) and platinum antitumor drugs are frequently used ototoxic agents to establish SNHL in animal models.
  • The efficacy of ototoxic agents in vivo is modulated by their chemical properties, animal species, administration route, and dosage.

Conclusions:

  • Animal models of drug-induced SNHL are valuable tools for investigating the intricacies of hearing.
  • These models aid in elucidating the functional roles of various auditory system components in humans.

Related Concept Videos